Boston Scientific Corporation BSX
NYSE
Recommendation
Dividend Power Score
Day's Range
$41.92$43.23
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.65% | -32.44% | 99.55% | -10.99% | -5.27% |
| Total Depreciation and Amortization | 1.69% | 1.14% | -3.84% | 6.73% | 1.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.32% | 132.40% | -349.42% | -14.85% | 352.50% |
| Change in Net Operating Assets | -232.43% | 108.09% | -690.32% | 252.27% | -81.12% |
| Cash from Operations | -28.90% | 323.56% | -74.49% | 1.56% | 4.43% |
| Capital Expenditure | 7.69% | -10.17% | 49.57% | -93.92% | -15.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -8.72% | 62.72% | -487.64% | 65.23% | 74.63% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.13% | -1,536.70% | 251.39% | -10.77% | -262.50% |
| Cash from Investing | 77.66% | -230.96% | -15.43% | -1.99% | 55.42% |
| Total Debt Issued | -140.12% | -- | -- | 100.00% | -200.00% |
| Total Debt Repaid | 100.00% | 94.98% | -23.92% | 2.79% | 31.53% |
| Issuance of Common Stock | 1,800.00% | -93.83% | 305.00% | -82.61% | 259.38% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 110.39% | 6.10% | -1,740.00% | 266.67% | 94.92% |
| Cash from Financing | -38.78% | -57.69% | -41.30% | -76.92% | 69.41% |
| Foreign Exchange rate Adjustments | 100.00% | -- | -- | 250.00% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | 200.00% | -- | -- | -- |
| Net Change in Cash | 104.94% | -76.59% | -175.11% | -8.71% | 512.92% |